BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36125788)

  • 21. Study protocol for the Melbourne Infant Study: BCG for Allergy and Infection Reduction (MIS BAIR), a randomised controlled trial to determine the non-specific effects of neonatal BCG vaccination in a low-mortality setting.
    Messina NL; Gardiner K; Donath S; Flanagan K; Ponsonby AL; Shann F; Robins-Browne R; Freyne B; Abruzzo V; Morison C; Cox L; Germano S; Zufferey C; Zimmermann P; Allen KJ; Vuillermin P; South M; Casalaz D; Curtis N
    BMJ Open; 2019 Dec; 9(12):e032844. PubMed ID: 31843845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal Priming: Bacillus Calmette-Guérin (BCG) Vaccine Scarring in Mothers Enhances the Survival of Their Child With a BCG Vaccine Scar.
    Berendsen MLT; Øland CB; Bles P; Jensen AKG; Kofoed PE; Whittle H; de Bree LCJ; Netea MG; Martins C; Benn CS; Aaby P
    J Pediatric Infect Dis Soc; 2020 Apr; 9(2):166-172. PubMed ID: 30715451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Bacillus Calmette-Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study.
    Liao Q; Zheng Y; Wang Y; Ye L; Liu X; Jiao W; Liu Y; Zhu Y; Jia J; Sun L; Shen A; Wan C
    Int J Infect Dis; 2022 Aug; 121():113-119. PubMed ID: 35429637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacillus Calmette-Guérin immunisation at birth and morbidity among Danish children: A prospective, randomised, clinical trial.
    Thøstesen LM; Nissen TN; Kjærgaard J; Pihl GT; Birk NM; Benn CS; Greisen G; Kofoed PE; Pryds O; Ravn H; Jeppesen DL; Aaby P; Stensballe LG
    Contemp Clin Trials; 2015 May; 42():213-8. PubMed ID: 25896113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature.
    Brewer TF
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S64-7. PubMed ID: 11010824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravesical Therapy for the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Chou R; Selph S; Buckley DI; Fu R; Griffin JC; Grusing S; Gore JL
    J Urol; 2017 May; 197(5):1189-1199. PubMed ID: 28027868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological and educational interventions for atopic eczema in children.
    Ersser SJ; Cowdell F; Latter S; Gardiner E; Flohr C; Thompson AR; Jackson K; Farasat H; Ware F; Drury A
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD004054. PubMed ID: 24399641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Immunodeficiency Diseases and Bacillus Calmette-Guérin (BCG)-Vaccine-Derived Complications: A Systematic Review.
    Fekrvand S; Yazdani R; Olbrich P; Gennery A; Rosenzweig SD; Condino-Neto A; Azizi G; Rafiemanesh H; Hassanpour G; Rezaei N; Abolhassani H; Aghamohammadi A
    J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1371-1386. PubMed ID: 32006723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravesical bacillus Calmette-Guerin versus mitomycin C for Ta and T1 bladder cancer.
    Shelley MD; Court JB; Kynaston H; Wilt TJ; Coles B; Mason M
    Cochrane Database Syst Rev; 2003; (3):CD003231. PubMed ID: 12917955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacille Calmette-Guérin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial.
    Nissen TN; Birk NM; Smits G; Jeppesen DL; Stensballe LG; Netea MG; van der Klis F; Benn CS; Pryds O;
    Vaccine; 2017 Apr; 35(16):2084-2091. PubMed ID: 28318766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-Specific Effects of Bacillus Calmette-Guérin: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Trunk G; Davidović M; Bohlius J
    Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low birth weight infants and Calmette-Guérin bacillus vaccination at birth: community study from Guinea-Bissau.
    Roth A; Jensen H; Garly ML; Djana Q; Martins CL; Sodemann M; Rodrigues A; Aaby P
    Pediatr Infect Dis J; 2004 Jun; 23(6):544-50. PubMed ID: 15194836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal Bacille Calmette-Guérin vaccination and tuberculin skin test reactions at 2- and 6-months: Effects on mortality up to 1 year of age.
    Schaltz-Buchholzer F; Roth A; de Bree LCJ; Biering-Sørensen S; Timmermann CAG; Monteiro I; Aaby P; Benn CS
    Vaccine; 2021 Dec; 39(50):7286-7294. PubMed ID: 34226104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India.
    Zodpey SP; Ambadekar NN; Thakur A
    Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacille-Calmette-Guerin vaccination and the development of allergic disease in children: a randomized, prospective, single-blind study.
    Steenhuis TJ; van Aalderen WM; Bloksma N; Nijkamp FP; van der Laag J; van Loveren H; Rijkers GT; Kuis W; Hoekstra MO
    Clin Exp Allergy; 2008 Jan; 38(1):79-85. PubMed ID: 17956585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Vaccination With Bacille Calmette-Guérin-Denmark or BCG-Japan Versus BCG-Russia to Healthy Newborns in Guinea-Bissau: A Randomized Controlled Trial.
    Schaltz-Buchholzer F; Bjerregaard-Andersen M; Øland CB; Golding C; Stjernholm EB; Monteiro I; Aaby P; Benn CS
    Clin Infect Dis; 2020 Nov; 71(8):1883-1893. PubMed ID: 31677386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse reactions to the Bacillus Calmette-Guérin (BCG) vaccine in new-born infants-an evaluation of the Danish strain 1331 SSI in a randomized clinical trial.
    Nissen TN; Birk NM; Kjærgaard J; Thøstesen LM; Pihl GT; Hoffmann T; Jeppesen DL; Kofoed PE; Greisen G; Benn CS; Aaby P; Pryds O; Stensballe LG
    Vaccine; 2016 May; 34(22):2477-82. PubMed ID: 27060379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-Dose Versus Standard Dose of Bacillus Calmette-Guerin in the Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis.
    Zeng S; Yu X; Ma C; Zhang Z; Song R; Chen X; Sun Y; Xu C
    Medicine (Baltimore); 2015 Dec; 94(49):e2176. PubMed ID: 26656345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smallpox and BCG vaccination in childhood and cutaneous malignant melanoma in Danish adults followed from 18 to 49 years.
    Rieckmann A; Meyle KD; Rod NH; Baker JL; Benn CS; Aaby P; Sørup S
    Vaccine; 2019 Oct; 37(44):6730-6736. PubMed ID: 31537447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.